Paul Donovan
Paul Donovan
action bearing believe issue legal proposed threats
We believe this issue has no bearing on our proposed acquisition of Guidant. Unfortunately, threats of legal action are commonplace in our industry.
agreement believe continue definitive diligence due employees forward goal johnson move offering potential proposal reaching revised strong upside
We continue to believe our $72 proposal is better for Guidant, its shareholders and its employees than Johnson & Johnson's revised offer. We are offering significantly more value, and there is strong upside potential over time. We continue to move forward on our due diligence with the goal of reaching a definitive agreement with Guidant.
agreement believe continue definitive diligence due employees forward goal johnson move offering potential proposal reaching revised strong upside
We continue to believe our $72 (per share) proposal is better for Guidant, its shareholders and its employees than Johnson & Johnson's revised offer. We are offering significantly more value, and there is strong upside potential over time. We continue to move forward on our due diligence with the goal of reaching a definitive agreement with Guidant.
believe close
We believe we can close by the end of March.
believe close commission conclude date due easter europe few goal holiday pushes review week
The Easter holiday in Europe pushes the due date back a few days, but we still believe the Commission may conclude its review before that date, and our goal is still to close during the first week of April.
beat believe consensus estimates good met street wall
It was a very good quarter. We beat Wall Street consensus estimates for revenue, and we believe we met them for earnings.
believe employees johnson offering potential proposal revised strong upside
We believe our $72 proposal is better for Guidant, its shareholders and its employees than Johnson & Johnson's revised offer. We are offering significantly more value, and there is strong upside potential over time.
believe continue employees johnson offering potential proposal revised strong upside
We continue to believe our $72 (a share) proposal is better for Guidant, its shareholders and its employees than Johnson & Johnson's revised offer. We are offering significantly more value, and there is strong upside potential over time.
access changes designed ensure final fullest innovative possible recommend regulation
We will recommend changes designed to ensure that the final regulation preserves the fullest possible beneficiary access to innovative technologies and therapies.
agreement continue definitive diligence due forward goal move reaching
We continue to move forward with our due diligence with the goal of reaching a definitive agreement with Guidant.
agreement continue definitive diligence due forward goal move reaching
We continue to move forward on our due diligence with the goal of reaching a definitive agreement with Guidant. I don't think we're going to have anything more to say right now.
agreement continue definitive expect position sign weeks
We continue to expect to be in a position to sign a definitive agreement in the first two weeks of January.
businesses commodity costs empty lower moment problem production
Unfortunately, I don't think this is an empty threat. The problem for Philips is they are in such commodity businesses at the moment and production costs are much lower in Asia.
few
We should have things re-stocked in a few weeks.